Merck Completes Tender Offer to Acquire Cubist

Dateline City:

KENILWORTH, N.J.

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada,
announced the successful completion of the tender offer for all of the
outstanding shares of common stock of Cubist Pharmaceuticals, Inc.
(NASDAQ: CBST) at a purchase price of $102.00 per share.
Language:

English

Contact:

MerckMedia:Lainie Keller, 908-236-5036orSteve Cragle, 908-740-1801orInvestor:Joe Romanelli, 908-740-1986orJustin Holko, 908-740-1879

Ticker Slug:

Ticker: MRK Exchange: NYSE

read more

Source: Merck.com - Corporate News - January 21, 2015 Category: Pharmaceuticals Tags: Corporate News Financial News Latest News Source Type: news